Ulus S. Akarca

Ege, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

When viral quiescence meets metabolic injury: Rethinking risk and treatment at the intersection of MASLD and chronic hepatitis B.

When viral quiescence meets metabolic injury: Rethinking risk and treatment at the intersection of MASLD and chronic hepatitis B.

Journal: Hepatology forum

Published: January 13, 2026

Terlipressin Treatment for Acute Esophageal Variceal Bleeding: Bolus or Infusion?

Terlipressin Treatment for Acute Esophageal Variceal Bleeding: Bolus or Infusion?

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: December 18, 2025

Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.

Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.

Journal: Journal of hepatology

Published: November 12, 2025

siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares.

siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares.

Journal: Journal of hepatology

Published: November 05, 2025

siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares.

siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares.

Journal: Journal of hepatology

Published: November 05, 2025

Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.

Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.

Journal: United European gastroenterology journal

Published: October 21, 2025

Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study.

Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study.

Journal: Biomedicines

Published: June 07, 2025

Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye.

Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye.

Journal: Scientific reports

Published: January 13, 2025

Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis.

Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis.

Journal: Acta gastro-enterologica Belgica

Published: August 30, 2024

Performance of non-invasive fibrosis markers in biopsy-proven liver disorders.

Performance of non-invasive fibrosis markers in biopsy-proven liver disorders.

Journal: Hepatology forum

Published: July 29, 2024

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection.

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection.

Journal: Journal of viral hepatitis

Published: June 03, 2024

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

Journal: The New England journal of medicine

Published: November 14, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026